Eton Pharmaceuticals (NASDAQ:ETON) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Those who invested in Eton Pharmaceuticals (NASDAQ:ETON) three years ago are up 483% [Yahoo! Finance]
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
Eton Pharmaceuticals (NASDAQ:ETON) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th